- Home
- OSW vs TARS Comparison
OSW vs TARS Comparison
Compare OSW & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSW | TARS |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | Bahamas | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OSW | TARS |
|---|---|---|
| Price | $28.20 | $62.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $27.00 | ★ $89.00 |
| AVG Volume (30 Days) | ★ 802.3K | 529.2K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | N/A | ★ 48.21 |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $961,001,000.00 | $451,360,000.00 |
| Revenue This Year | $7.49 | $56.43 |
| Revenue Next Year | $8.52 | $30.19 |
| P/E Ratio | $129.81 | ★ N/A |
| Revenue Growth | 7.37 | ★ 146.71 |
| 52 Week Low | $19.06 | $38.51 |
| 52 Week High | $29.25 | $85.25 |
Technical Indicators
Market Signals| Indicator | OSW | TARS |
|---|---|---|
| Relative Strength Index (RSI) | 69.73 | 46.90 |
| Support Level | $19.70 | $60.95 |
| Resistance Level | N/A | $66.36 |
| Average True Range (ATR) | 1.16 | 2.87 |
| MACD | 0.27 | 0.39 |
| Stochastic Oscillator | 82.98 | 27.43 |
Price Performance
Historical ComparisonAbout OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.